Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 1
2009 1
2010 1
2011 2
2012 1
2013 6
2014 3
2015 4
2016 2
2017 1
2018 1
2019 1
2020 9
2021 2
2022 3
2023 2
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Results by year

Filters applied: . Clear all
Page 1
Giant cell myositis and myocarditis revisited.
Oflazer P. Oflazer P. Acta Myol. 2020 Dec 1;39(4):302-306. doi: 10.36185/2532-1900-033. eCollection 2020 Dec. Acta Myol. 2020. PMID: 33458585 Free PMC article. Review.
268th ENMC workshop - Genetic diagnosis, clinical classification, outcome measures, and biomarkers in Facioscapulohumeral Muscular Dystrophy (FSHD): Relevance for clinical trials.
Montagnese F, de Valle K, Lemmers RJLF, Mul K, Dumonceaux J, Voermans N; 268th ENMC workshop participants. Montagnese F, et al. Neuromuscul Disord. 2023 May;33(5):447-462. doi: 10.1016/j.nmd.2023.04.005. Epub 2023 Apr 8. Neuromuscul Disord. 2023. PMID: 37099914 No abstract available.
Meeting report: The 2023 FSHD International Research Congress.
Arjomand J, Gabellini D, Voermans N; 2023 FSHD International Research Congress Program Committee. Arjomand J, et al. Neuromuscul Disord. 2024 Feb;35:53-57. doi: 10.1016/j.nmd.2023.10.018. Epub 2023 Nov 2. Neuromuscul Disord. 2024. PMID: 37978033
The clinical use of impulse oscillometry in neuromuscular diseases.
Iliaz S, Yunisova G, Cakmak OO, Celebi O, Bulus E, Duman A, Bayraktaroglu M, Oflazer P. Iliaz S, et al. Among authors: oflazer p. Respir Med. 2022 Aug-Sep;200:106931. doi: 10.1016/j.rmed.2022.106931. Epub 2022 Jul 15. Respir Med. 2022. PMID: 35858508
Recurrent de-novo gain-of-function mutation in SPTLC2 confirms dysregulated sphingolipid production to cause juvenile amyotrophic lateral sclerosis.
Dohrn MF, Beijer D, Lone MA, Bayraktar E, Oflazer P, Orbach R, Donkervoort S, Foley AR, Rose A, Lyons M, Louie RJ, Gable K, Dunn T, Chen S, Danzi MC, Synofzik M, Bönnemann CG, Nazlı Başak A, Hornemann T, Zuchner S. Dohrn MF, et al. Among authors: oflazer p. J Neurol Neurosurg Psychiatry. 2024 Feb 14;95(3):201-205. doi: 10.1136/jnnp-2023-332130. J Neurol Neurosurg Psychiatry. 2024. PMID: 38041684 Free PMC article.
Best practice guidelines on genetic diagnostics of facioscapulohumeral muscular dystrophy: Update of the 2012 guidelines.
Giardina E, Camaño P, Burton-Jones S, Ravenscroft G, Henning F, Magdinier F, van der Stoep N, van der Vliet PJ, Bernard R, Tomaselli PJ, Davis MR, Nishino I, Oflazer P, Race V, Vishnu VY, Williams V, Sobreira CFR, van der Maarel SM, Moore SA, Voermans NC, Lemmers RJLF. Giardina E, et al. Among authors: oflazer p. Clin Genet. 2024 Apr 29. doi: 10.1111/cge.14533. Online ahead of print. Clin Genet. 2024. PMID: 38685133 Review.
1st FSHD European Trial Network workshop:Working towards trial readiness across Europe.
Voermans NC, Vriens-Munoz Bravo M, Padberg GW, Laforêt P; FSHD European Trial Network workshop study group; van Alfen N, Attarian S, Badrising UA, Bugiardini P, Camano González P, Carlier RY, Desguerre I, Diaz-Manera J, Dumonceaux J, van Engelen BG, Evangelista T, Khosla S, Lópezde Munain A, van der Maarel SM, Mejat A, Monforte M, Montagnese F, Mul K, Oflazer P, Porter B, Quijano Roy S, Ricci E, Sacconi S, Sansone VA, Schoser B, Statland J, Stumpe E, Tasca G, Tawil R, Turner C, Vissing J. Voermans NC, et al. Among authors: oflazer p. Neuromuscul Disord. 2021 Sep;31(9):907-918. doi: 10.1016/j.nmd.2021.07.013. Epub 2021 Jul 24. Neuromuscul Disord. 2021. PMID: 34404575 No abstract available.
Cortical excitability in Duchenne muscular dystrophy.
Yayla V, Oge AE, Deymeer F, Gurvit H, Akca-Kalem S, Parman Y, Oflazer P. Yayla V, et al. Among authors: oflazer p. Clin Neurophysiol. 2008 Feb;119(2):459-65. doi: 10.1016/j.clinph.2007.09.125. Epub 2007 Nov 28. Clin Neurophysiol. 2008. PMID: 18053763
39 results